
Retatrutide 10mg Research Vial
Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling.
Retatrutide 20mg is a lyophilised research peptide in a sealed vial, intended for laboratory studies of metabolic and receptor pathways.

Retatrutide 20mg is a lyophilised research peptide in a sealed vial, intended for laboratory studies of metabolic and receptor pathways.
Price shown is for a single 20mg vial. The final amount is confirmed at checkout. Need a different amount? Send an inquiry.
Retatrutide 20mg is a lyophilised research peptide in a sealed vial, intended for laboratory studies of metabolic and receptor pathways. The 20mg vial is a mid-range option in the Retatrutide line, suited to labs that need enough material for several experimental runs. Retatrutide itself is a triple-receptor peptide examined in the literature for its behaviour at GLP-1, GIP and glucagon targets. It is provided as a stable lyophilised powder, sealed and labelled with the stated 20mg amount. The matching batch report documents identity, purity and the CAS number 2381089-83-2 for the lot. This product is Research Use Only and carries no therapeutic claim. This listing is for the 20mg vial. The material is identified by CAS number 2381089-83-2. The current batch report records a measured purity of 99.739%.
| Labelled amount | 20mg |
|---|---|
| Form | Lyophilised powder |
| CAS number | 2381089-83-2 |
| Intended use | In vitro laboratory research |
Every vial is supplied with an analytical report prepared for its own batch. The report records identity and purity results for the submitted sample. Match the batch identifier on the report to the vial you receive before use.
Retatrutide 20mg is a lyophilised research peptide in a sealed vial, intended for laboratory studies of metabolic and receptor pathways. It is supplied as a lyophilised, sealed research vial and is not a medicine.
The vial is labelled with a nominal 20mg of material. The figure is the stated content of the vial, not a solution concentration, and should be checked against the batch documentation before use.
Yes. Each listing links to the analytical report prepared for the specific batch. The report records identity and purity results for the submitted sample and should be matched to the vial you receive.
It arrives as a freeze-dried powder in a sealed vial. Keep the container closed and follow the storage conditions printed on the label and any handling sheet supplied with the lot.
No. AthloPep supplies this material for in vitro laboratory research only. It is not for human or animal consumption and no therapeutic use is implied.
The listed unit price for this vial is $138.6. Prices are shown in US dollars and the final amount is confirmed on the checkout page before payment.

Retatrutide 10mg is a lyophilised research peptide supplied as a single, sealed vial for controlled in vitro studies of metabolic signalling.

Retatrutide 15mg is a lyophilised research peptide supplied as a single, sealed vial for metabolic receptor studies in vitro.

Retatrutide 30mg is a sealed, lyophilised research vial for in vitro work on metabolic receptor signalling.

Retatrutide 40mg is a lyophilised research peptide supplied in a sealed vial for higher-volume in vitro metabolic studies.
Tell us what you need. An email address is required so we can reply.